SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001885524-21-000004
Filing Date
2021-10-04
Accepted
2021-10-04 13:50:34
Documents
1
Period of Report
2021-09-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 2217
  Complete submission text file 0001885524-21-000004.txt   4091
Mailing Address 200 PARK AVENUE 7TH FLOOR NEW YORK NY 10166
Business Address 200 PARK AVENUE 7TH FLOOR NEW YORK NY 10166 212-922-7468
Alcentra NY, LLC (Reporting) CIK: 0001622583 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 811-23330 | Film No.: 211301920

Mailing Address C/O BNY MELLON INVESTMENT ADVISER, INC. 240 GREENWICH STREET NEW YORK NY 10286
Business Address C/O BNY MELLON INVESTMENT ADVISER, INC. 240 GREENWICH STREET NEW YORK NY 10286 212-922-6400
BNY Mellon Alcentra Global Multi-Strategy Credit Fund, Inc. (Issuer) CIK: 0001729678 (see all company filings)

IRS No.: 000000000 | State of Incorp.: MD | Fiscal Year End: 0331